Publication | Closed Access

Additive effect of the metabolic syndrome score to the conventional CHADS2 score for the thromboembolic risk stratification of patients with atrial fibrillation

Metabolic Syndrome ScoreThrombosisMetabolic SyndromeVenous ThrombosisCardiovascular DiseaseAtherosclerosisMedicineFibrinolysisCoagulopathyAtrial FibrillationPublic HealthPlatelet AntagonistStrokeAnticoagulantCardiologyAdditive EffectEpidemiology